Eshera, Noha BSc1; Itana, Hawi BSc1; Zhang, Lei PhD2; Soon, Greg PhD3; Fadiran, Emmanuel O. PhD1,*
Author Information
1Office of Women's Health (OWH), Office of the Commissioner (OC), Food and Drug Administration, Silver Spring, MD;
2Office of Clinical Pharmacology, Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration, Silver Spring, MD; and
3Office of Biostatistics, OTS, CDER, Food and Drug Administration, Silver Spring, MD.
Address for correspondence: Food and Drug Administration, Office of Women's Health, Building 32, Room 2312, 10903 New Hampshire Avenue, Silver Spring, MD 20993. E-mail: [email protected]
The authors have no conflicts of interest to declare.
The article reflects the views of the authors and should not be construed to represent FDA's views or policies.
doi: 10.1097/MJT.0000000000000177
